If you are a healthcare professional, this course gives you the knowledge and expertise to develop as a specialist prostate cancer practitioner. Through online learning you learn how to provide, promote and develop high standards of care.
The postgraduate certificate stage focuses on developing your clinical knowledge and skills. The prostate cancer module gives you an in-depth understanding of managing the stages of the disease including • the physical and psychosocial impact • treatment • the needs of those affected • how these needs can be addressed.
As advanced communication is essential to your clinical role, you also undertake a module on this subject. This helps you develop your knowledge of the concepts underpinning advanced communication strategies used in practice and encourages you to reflect on your skills development in this area too.
During the postgraduate diploma stage you develop your understanding of the wider specialist and advanced practice role in areas such as • leadership • peer support • education • service development and improvement.
You also expand your knowledge of high risk or high priority areas in practice, which you identify as relevant to your own local practice, such as • care of African Caribbean men • needs relating to sexual function • survivorship • end of life care.
This stage of the course also prepares you for undertaking research by improving your understanding of research methods and helping you develop a research question for investigation.
In the final masters stage you research a specific area of interest relevant to your professional role and priorities in practice. This enables you to specialise in your chosen topic, develop expertise and hopefully influence practice or policy.
Throughout your studies you are encouraged to reflect on your role as
You also evaluate your own practice and the practice of others to help you develop ideas for service improvement within your practice and workplace.
This is primarily a distance learning course using online learning. You must have internet access and be prepared to engage with technology. We supply you with a range of online learning and teaching resources, including access to library resources and information databases.
Each module provides clear guidance on how to approach your self-directed study. This learning is enhanced by online, tutor facilitated group discussions allowing you to share views and practice experiences with other students. These sessions are a popular and valuable learning resource, and are also used to support you in your final marked assessment.
Prostate Cancer UK is a registered charity in England and Wales (1005541) and in Scotland (SC039332). Registered company number 2653887.
The postgraduate certificate (PgCert) is achieved by successfully completing 60 credits.
The postgraduate diploma (PgDip) is achieved by successfully completing 120 credits.
The masters (MSc) award is achieved by successfully completing 180 credits.
Postgraduate certificate core modules
Postgraduate diploma core modules
You choose a further 30 credits from the following modules:
If you are a specialist practitioner in prostate cancer care, this course enables you to continue your academic and professional development and validate your role. You can tailor your learning, allowing you to specialise in areas such as palliative and end of life care, survivorship and rehabilitation.
If working towards a specialist practitioner role, the course equips you with core knowledge and skills to help you perform at the necessary practice level.
The course provides academic and professional skills relevant to the role of an advanced/specialist practitioner, as defined by professional bodies such as the Royal College of Nursing and the College of Radiographers.
The course also provides opportunities to be involved in research and service development activities in a professional, clinical or academic setting. You are encouraged to share your learning and research through article publication or conference presentation, helping to raise your profile in this field.
As well as specialist clinical roles, you may also pursue academic teaching or research careers in the UK or internationally.
This Masters in Cancer Sciences will prepare you for a career in cancer science, whether you aim to pursue a PhD or further medical studies, or seek a career in the health services sector, in the life sciences, biotechnology or pharmaceutical industries. Our programme takes a 'bench to bedside' approach, enabling graduates to work within a multidisciplinary environment of world-leading scientists and cancer-specialists to address the latest challenges in cancer research.
This 13 week core course aims to:
One week of practical training is provided at the start of the course. This course is assessed through a lab notebook, group assessment, critical essay and an exam that focuses on data analysis and interpretation.
In the second semester, you can choose from a range of 3 week optional courses, before taking the core course “Designing a Research Project”.
In this 14 week core course you will:
Note: students must have a minimum of grade C in semesters 1 and 2 in order to proceed to the research project.
The knowledge and transferable skills developed in this programme will be suitable for those contemplating a PhD or further medical studies, those wishing to work in the health services sector, and those interested in working in the life sciences, biotechnology or pharmaceutical industries, including contract research organisations (CROs). This programme is designed for students with undergraduate degrees in the life sciences, scientists working in the pharmaceutical and biotechnology industries, and clinicians and other healthcare professionals.
The MSc in Clinical Leadership in Cancer, Palliative and End of Life Care is an inter-professional programme for healthcare practitioners who wish to develop the qualities required for clinical leadership and advanced practice in cancer, palliative or end of life care. Our goal is to produce clinical leaders who will be the drivers for change; providing expert care, developing those you work with and influencing the shape of care to make services better for patients.
This MSc option is very flexible, with students able to complete the course over one year full time, and up to five years part time. The blended approach to teaching and learning also means that some parts of the programme can be completed as distance learning. A diverse range of national and international practitioners have completed the programme including physiotherapists, occupational therapists, doctors, acute care nurse specialists and nursing home practitioners, and those from Mexico, Brazil, Ghana, Malawi and Saudi Arabia.
This programme will enable you to develop the qualities needed by ‘practice leaders …who are firmly grounded in direct care provision or clinical work with patients, families and populations … constantly working to improve the quality of services and patient care’ (DH, 2010:7). They include clinical acumen (the ability to lead and manage complex care), clinical interpretation (the ability to interpret policy and research, and design and lead clinical services fit for purpose), and clinical relationships (the ability to develop others and foster excellence).
The programme has been mapped to the attributes of advanced level practice outlined by government bodies in the United Kingdom (Department of Health 2010, National Health Service Scotland 2008). UK professionals who may need to demonstrate their advanced level attributes to registration bodies will be able to do so through the completion of this programme.
The key features of this programme are:
Our MRes Experimental Cancer Medicine master's course will give nurses, doctors and clinical researchers the skills needed to work in early phase clinical studies.
You will learn how to master experimental cancer through a combination of traditional teaching and hands-on learning, spending a year as a member of the Experimental Cancer Medicine Team at The Christie while also taking four structured taught units.
The taught units will see you learn the details of designing and delivering Phase 1 clinical studies, understanding the pre-clinical data required before a clinical programme can commence, and how to optimise early clinical studies to provide evidence for progressing a promising drug into Phase II/III clinical testing.
Alongside the taught elements, you will be allocated to one or more clinical trials that are being conducted by The Christie experimental cancer medicine team. You will have a named trainer and be exposed to tasks required in the setup, delivery, interpretation and audit of a clinical study.
Nursing and physician students will be expected to participate in patient care, including new and follow-on patient clinics, treatment and care-giving episodes with patients.
For clinical trials coordinators, no direct patient contact is envisaged and duties will involve clinical trial setup, protocol amendments, database setup, data entry, costing and billing for clinical research.
You will be able to choose two aspects of your direct clinical trial research experience to write up for your two research projects in a dissertation format. This will give you the skills and knowledge required to critically report medical, scientific and clinically related sciences for peer review.
The primary purpose of the MRes in Experimental Cancer Medicine is to provide you with the opportunity to work within a premier UK Phase 1 cancer clinical trials unit and, through a mix of taught and experiential learning, master the discipline of Experimental Cancer Medicine.
Extensive practical experience
You will spend most of your time gaining hands-on experience within The Christie's Experimental Cancer Medicine Team.
Meet the course team
Dr Natalie Cook is a Senior Clinical Lecturer in Experimental Cancer Medicine at the University and Honorary Consultant in Medical Oncology at The Christie. She completed a PhD at Cambridge, investigating translational therapeutics and biomarker assay design in pancreatic cancer.
Professor Hughes is Chair of Experimental Cancer Medicine at the University and Strategic Director of the Experimental Cancer Medicine team at The Christie. He is a member of the research strategy group for Manchester Cancer Research Centre. He serves on the Biomarker evaluation review panel for CRUK grant applications.
Professor Hughes was previously Global Vice-President for early clinical development at AstraZeneca, overseeing around 100 Phase 0/1/2 clinical studies. He was previously Global Vice-President for early phase clinical oncology, having been involved in over 200 early phase clinical studies.
Dr Matthew Krebs is a Clinical Senior Lecturer in Experimental Cancer Medicine at the University and Honorary Consultant in Medical Oncology at The Christie.
He has a PhD in circulating biomarkers and postdoctoral experience in single cell and ctDNA molecular profiling. He is Principal Investigator on a portfolio of phase 1 clinical trials and has research interests in clinical development of novel drugs for lung cancer and integration of biomarkers with experimental drug development.
Our course is structured around a 2:1 split between clinical-based research projects and taught elements respectively.
Taught course units will predominantly use lectures and workshops.
For the research projects, teaching and learning will take place through one-to-one mentoring from a member of the Experimental Cancer Medicine team.
The clinical and academic experience of contributors to this course will provide you with an exceptional teaching and learning experience.
You will be assessed through oral presentations, single best answer exams, written reports and dissertation.
For each research project, you will write a dissertation of 10,000 to 15,000 words. Examples of suitable practical projects include the following.
Publication-based/dissertation by publication
Service development/professional report/ report based dissertation
Adapted systematic review (qualitative data)
Full systematic review that includes data collection (quantitative data)
Qualitative or quantitative empirical research
Qualitative secondary data analysis/analysis of existing quantitative data
Quantitative secondary data analysis/analysis of existing qualitative data/theoretical study/narrative review
Teaching will take place within The Christie NHS Foundation Trust , Withington.
Practical support and advice for current students and applicants is available from the Disability Advisory and Support Service. Email: [email protected]
This course is relevant to physician, nursing and clinical research students who are considering a career in Phase 1 clinical studies.
The course provides a theoretical and experiential learning experience and offers a foundation for roles within other experimental cancer medicine centres within the UK and EU, as well as careers in academia, the pharmaceutical industry, clinical trials management and medicine.
The MRes is ideal for high-calibre graduates and professionals wishing to undertake directly channelled research training in the clinical and medical oncology field.